Tosoian et al reported updated Partin tables for men with clinically localized prostate cancer. The authors are from the Johns Hopkins University.
Patient selection: male with clinically localized prostate cancer
Parameters:
(1) T code from T1c to T2c
(2) serum PSA in ng/mL
(3) Gleason score
OC = organ confined
ECE = extracapsular extension
SV = seminal vesicle involvement
LN = lymph node metastases
T Code |
PSA |
GS |
OC |
ECE |
SV+ |
LN+ |
T1c |
0 to 4.0 |
6 |
92 |
8 |
1 |
0 |
|
|
3+4 |
77 |
20 |
2 |
1 |
|
|
4+3 or 8 |
67 |
24 |
7 |
2 |
|
|
9 or 10 |
50 |
31 |
13 |
6 |
|
4.1 to 6.0 |
6 |
90 |
9 |
1 |
0 |
|
|
3+4 |
74 |
23 |
2 |
1 |
|
|
4+3 or 8 |
64 |
28 |
6 |
2 |
|
|
9 or 10 |
47 |
35 |
12 |
5 |
|
6.1 to 10 |
6 |
87 |
12 |
1 |
0 |
|
|
3+4 |
67 |
28 |
4 |
1 |
|
|
4+3 or 8 |
53 |
32 |
11 |
4 |
|
|
9 or 10 |
35 |
36 |
19 |
9 |
|
> 10 |
6 |
80 |
17 |
3 |
1 |
|
|
3+4 |
52 |
34 |
8 |
5 |
|
|
4+3 or 8 |
35 |
33 |
20 |
11 |
|
|
9 or 10 |
19 |
30 |
28 |
22 |
T2a |
0 to 4.0 |
6 |
88 |
11 |
1 |
0 |
|
|
3+4 |
70 |
27 |
2 |
1 |
|
|
4+3 or 8 |
58 |
31 |
7 |
3 |
|
|
9 or 10 |
41 |
38 |
13 |
7 |
|
4.1 to 6.0 |
6 |
87 |
12 |
1 |
0 |
|
|
3+4 |
66 |
30 |
2 |
1 |
|
|
4+3 or 8 |
55 |
35 |
7 |
3 |
|
|
9 or 10 |
38 |
42 |
12 |
6 |
|
6.1 to 10 |
6 |
82 |
16 |
1 |
0 |
|
|
3+4 |
58 |
36 |
4 |
2 |
|
|
4+3 or 8 |
45 |
39 |
11 |
4 |
|
|
9 or 10 |
28 |
42 |
18 |
10 |
|
> 10 |
6 |
73 |
22 |
3 |
1 |
|
|
3+4 |
43 |
42 |
9 |
6 |
|
|
4+3 or 8 |
28 |
39 |
20 |
13 |
|
|
9 or 10 |
14 |
34 |
26 |
24 |
T2b/T2c |
0 to 4.0 |
6 |
79 |
19 |
1 |
1 |
|
|
3+4 |
52 |
40 |
5 |
4 |
|
|
4+3 or 8 |
37 |
40 |
12 |
10 |
|
|
9 or 10 |
21 |
40 |
18 |
21 |
|
4.1 to 6.0 |
6 |
76 |
22 |
1 |
0 |
|
|
3+4 |
48 |
44 |
4 |
4 |
|
|
4+3 or 8 |
35 |
44 |
11 |
9 |
|
|
9 or 10 |
20 |
44 |
17 |
19 |
|
6.1 to 10 |
6 |
69 |
27 |
3 |
1 |
|
|
3+4 |
38 |
48 |
7 |
6 |
|
|
4+3 or 8 |
25 |
44 |
17 |
14 |
|
|
9 or 10 |
13 |
38 |
22 |
26 |
|
> 10 |
6 |
54 |
34 |
6 |
5 |
|
|
3+4 |
23 |
46 |
12 |
18 |
|
|
4+3 or 8 |
12 |
33 |
22 |
32 |
|
|
9 or 10 |
5 |
23 |
23 |
48 |
Specialty: Hematology Oncology